BlackBarn Capital Partners LP
NEW YORK, NY
$402m in 17 US stocks at the end of 30 June 2026. The top 10 are 81.4% of the money. It changed about 23.7% of the portfolio this quarter.
Value
$402m
Stocks
17
Top 10 share
81.4%
Turnover
23.7%
What changed this quarter
New
Bought for the first time this quarter.
- UnitedHealth GroupUNH6.7% of the fund
- Venture GlobalVG4.8% of the fund
- Azul S AAZUL3.8% of the fund
- Occidental PetroleumOXY3.0% of the fund
- California ResourcesCRC2.3% of the fund
Added
Bought more of a stock they already held.
- NIQ Global IntelligenceNIQ6.8% of the fund+40%
- NXP SemiconductorsNXPI6.3% of the fund+50%
- McGraw HillMH5.8% of the fund+17%
Cut
Sold some of their stake.
- Roivant SciencesROIV17.6% of the fund-12%
- Diversified Healthcare TrustDHC9.4% of the fund-15%
- Viking TherapeuticsVKTX5.8% of the fund-3%
- Amneal PharmaceuticalsAMRX5.6% of the fund-21%
- Cogent Communications HoldingsCCOI0.9% of the fund-50%
Sold out
Sold their entire stake.
Holdings
- Azul S AAZUL
- Share
- 3.8%
- Value
- $15m
- Shares
- 1,684,188
New
| Company | Share of fund | Value | Shares | Change |
|---|---|---|---|---|
| Roivant SciencesROIV | 17.6% | $71m | 2,000,000 | -12% |
| Privia Health GroupPRVA | 10.1% | $41m | 1,585,000 | Held |
| Diversified Healthcare TrustDHC | 9.4% | $38m | 4,075,000 | -15% |
| NextEra EnergyNEE | 7.3% | $29m | 335,000 | Held |
| NIQ Global IntelligenceNIQ | 6.8% | $27m | 2,903,862 | +40% |
| UnitedHealth GroupUNH | 6.7% | $27m | 65,000 | New |
| NXP SemiconductorsNXPI | 6.3% | $25m | 90,000 | +50% |
| Viking TherapeuticsVKTX | 5.8% | $23m | 600,000 | -3% |
| McGraw HillMH | 5.8% | $23m | 2,450,000 | +17% |
| Amneal PharmaceuticalsAMRX | 5.6% | $23m | 1,300,000 | -21% |
| Venture GlobalVG | 4.8% | $19m | 1,750,000 | New |
| Azul S AAZUL | 3.8% | $15m | 1,684,188 | New |
| Occidental PetroleumOXY | 3.0% | $12m | 250,000 | New |
| Arbutus BiopharmaABUS | 3.0% | $12m | 2,500,000 | Held |
| California ResourcesCRC | 2.3% | $9m | 175,000 | New |
| Cogent Communications HoldingsCCOI | 0.9% | $3m | 250,000 | -50% |
| Vivid SeatsSEAT | 0.8% | $3m | 500,000 | Held |
Options (7)
- State STR Spdr S&P 500 ETF TSPY
- Type
- Put
- Value
- $597m
- Contracts
- 800,000
- Oscar HealthOSCR
- Type
- Put
- Value
- $50m
- Contracts
- 1,750,000
- UnitedHealth GroupUNH
- Type
- Call
- Value
- $42m
- Contracts
- 100,000
- ResmedRMD
- Type
- Put
- Value
- $39m
- Contracts
- 200,000
- Venture GlobalVG
- Type
- Call
- Value
- $33m
- Contracts
- 3,000,000
- Warby ParkerWRBY
- Type
- Put
- Value
- $12m
- Contracts
- 400,000
- Viking TherapeuticsVKTX
- Type
- Call
- Value
- $10m
- Contracts
- 250,000
| Company | Type | Value | Contracts |
|---|---|---|---|
| State STR Spdr S&P 500 ETF TSPY | Put | $597m | 800,000 |
| Oscar HealthOSCR | Put | $50m | 1,750,000 |
| UnitedHealth GroupUNH | Call | $42m | 100,000 |
| ResmedRMD | Put | $39m | 200,000 |
| Venture GlobalVG | Call | $33m | 3,000,000 |
| Warby ParkerWRBY | Put | $12m | 400,000 |
| Viking TherapeuticsVKTX | Call | $10m | 250,000 |
Over time and by industry
Value over time
Jun '25
Dec '25
Jun '26
Value is up 33.3% since 30 June 2025.
Where the money is
Health care48.9%
Technology13.0%
Utilities12.2%
Real estate9.4%
Media & telecom6.6%
Energy5.3%
Retail & consumer0.8%
Other3.8%
From the fund's 13F filings. They list US stocks and options only, 45 days after each quarter, and leave out cash, bonds, shorts and foreign shares.